Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma

NCT04446663 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Neoplasms

Interventions

DRUG: Toripalimab
DRUG: Albumin-bound Paclitaxel
DRUG: Cisplatin
RADIATION: intensity-modulated radiotherapy

Sponsor

First People's Hospital of Foshan